RedHill Biopharma Ltd.
USD0.85
-0.01 (-1.66%)
CEO
Dror Ben-Asher
IPO Date
2013-01-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
IL
Open
$0.85
Prev. Close
$0.86
Day Low
$0.85
Day High
$0.85
52W Low
$0.71
52W High
$3.31
Market Cap
$0.00B
Volume
0.05M
| -1.9 |
| 31 Dec 2023 | FY | 47.0% | 366.2% | 1155.9% | 103.8% | 0.57 | 0.84 | 0.8 |
| 31 Dec 2022 | FY | 46.1% | -116.0% | 148.1% | -45.1% | -2.53 | 0.44 | -0.2 |
| 31 Dec 2021 | FY | 42.4% | -114.0% | -1101.3% | -53.9% | 9.89 | 1.09 | -2.5 |
| 31 Dec 2020 | FY | 42.7% | -118.4% | -549.4% | -42.3% | 6.27 | 0.96 | -7.7 |
| 31 Dec 2019 | FY | 64.1% | -672.5% | -70.5% | -57.1% | 0.06 | 5.01 | -8.5 |
| 31 Dec 2018 | FY | 66.1% | -464.4% | -75.8% | -62.2% | 0.00 | 5.47 | -6.6 |
| 31 Dec 2017 | FY | 46.9% | -1136.6% | -101.1% | -79.4% | 0.00 | 4.37 | -4.0 |
| 31 Dec 2016 | FY | -30140.6% | -29079.2% | -46.8% | -39.6% | 0.00 | 12.66 | -9.2 |
| 31 Mar 2025 | Q1 | 60.6% | -101.3% | 46.8% | -11.2% | -0.05 | 0.56 | -0.6 |
| 31 Dec 2024 | Q4 | 67.3% | -94.7% | 55.3% | -14.4% | -0.08 | 0.54 | -1.5 |
| 30 Sept 2024 | Q3 | 67.3% | -94.7% | 55.3% | -14.4% | -0.08 | 0.54 | -2.2 |
| 30 Jun 2024 | Q2 | 45.4% | -120.1% | -2531.1% | -7.0% | 9.15 | 0.74 | -3.5 |
| 31 Mar 2024 | Q1 | 45.4% | -120.1% | -2531.1% | -7.0% | 9.15 | 0.74 | -5.2 |
| 31 Dec 2023 | Q4 | 8.3% | -2386.4% | -654.6% | -58.8% | 0.57 | 0.81 | -0.5 |
| 30 Sept 2023 | Q3 | 8.3% | -2386.4% | -654.6% | -58.8% | 0.57 | 0.81 | -0.1 |
| 30 Jun 2023 | Q2 | 55.1% | 42.4% | 21.9% | 2.2% | 0.66 | 0.96 | 3.1 |